Literature DB >> 7668899

Effects of Th1 and Th2 cytokines on cytokine production and ICAM-1 expression on synovial fibroblasts.

J F Schlaak1, A Schwarting, P Knolle, K H Meyer zum Büschenfelde, W Mayet.   

Abstract

OBJECTIVES: To investigate the influence of the Th1 and Th2 lymphokines interleukins (IL)-4 and IL-13, interferon gamma (IFN gamma), and several monokines on the adhesion of mononuclear cells to synovial fibroblasts and intercellular adhesion molecule-1 (ICAM-1) expression and cytokine production of synovial fibroblasts in patients with osteoarthritis.
METHODS: Synovial fibroblasts were isolated from patients with osteoarthritis and stimulated with IL-1 beta, IL-4, IL-6, IL-10, IL-12, IL-13, tumour necrosis factor alpha (TNF alpha), and IFN gamma. Subsequently, we determined the production of IL-1 alpha, IL-1 beta, IL-6, IL-10, IL-12, IFN alpha and TNF alpha, and the expression of ICAM-1 lymphocyte function associated antigen 3 (LFA-3), BB7, and major histocompatibility complex class II molecules on these cells. Furthermore, the adhesion of freshly isolated mononuclear cells from the peripheral blood was tested using a colourimetric cell-cell adhesion assay.
RESULTS: Only production of IL-6 and the expression of ICAM-1 were observed. IL-1 beta and TNF alpha were the most potent stimulatory mediators of both cytokine production and ICAM-1 expression. IL-4 and IL-13 had differential effects as they upregulated cytokine production but downregulated IFN gamma induced ICAM-1 expression. In functional adhesion assays, TNF alpha, IL-1 alpha and, to a lesser extent, IFN gamma led to increased adhesion of mononuclear cells, whereas IL-4 and IL-13 had no effect.
CONCLUSIONS: Our data indicate that Th1 and Th2 lymphokines can modulate the function (cytokine production and expression of adhesion molecules) of synovial fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668899      PMCID: PMC1009935          DOI: 10.1136/ard.54.7.560

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  37 in total

1.  Interleukin-6 in synovial fluid from patients with arthritis.

Authors:  A Waage; C Kaufmann; T Espevik; G Husby
Journal:  Clin Immunol Immunopathol       Date:  1989-03

2.  Interleukin 4 inhibits polyclonal immunoglobulin secretion and cytokine production by peripheral blood mononuclear cells from rheumatoid arthritis patients.

Authors:  J Briolay; J Dechanet; D Blanchard; J Banchereau; P Miossec
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

3.  Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis.

Authors:  P Peichl; M Ceska; F Effenberger; G Haberhauer; H Broell; I J Lindley
Journal:  Scand J Immunol       Date:  1991-09       Impact factor: 3.487

4.  Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones.

Authors:  E Maggi; P Parronchi; R Manetti; C Simonelli; M P Piccinni; F S Rugiu; M De Carli; M Ricci; S Romagnani
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

5.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

Authors:  F Rousset; E Garcia; T Defrance; C Péronne; N Vezzio; D H Hsu; R Kastelein; K W Moore; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

6.  Phenotypic characteristics of T cells interacted with synovial cells.

Authors:  N Matsuoka; K Eguchi; A Kawakami; H Ida; M Nakashima; M Sakai; K Terada; S Inoue; Y Kawabe; A Kurata
Journal:  J Rheumatol       Date:  1991-08       Impact factor: 4.666

7.  Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4.

Authors:  T H Piela-Smith; G Broketa; A Hand; J H Korn
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

8.  Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions.

Authors:  W D Xu; G S Firestein; R Taetle; K Kaushansky; N J Zvaifler
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

9.  Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist.

Authors:  B Henderson; R C Thompson; T Hardingham; J Lewthwaite
Journal:  Cytokine       Date:  1991-05       Impact factor: 3.861

10.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Cytokines as biochemical markers for knee osteoarthritis.

Authors:  Thomas Mabey; Sittisak Honsawek
Journal:  World J Orthop       Date:  2015-01-18

2.  Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblasts.

Authors:  Claudia Jakubzick; Esther S Choi; Steven L Kunkel; Bharat H Joshi; Raj K Puri; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fluids.

Authors:  T Ushiyama; T Chano; K Inoue; Y Matsusue
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

4.  The roles of IFN-γ versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts.

Authors:  Hiroshi Kato; Judith Endres; David A Fox
Journal:  Mod Rheumatol       Date:  2013-01-11       Impact factor: 3.023

5.  T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis.

Authors:  L I Sakkas; C Scanzello; N Johanson; J Burkholder; A Mitra; P Salgame; C D Katsetos; C D Platsoucas
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

Review 6.  Osteoarthritis: can anti-cytokine therapy play a role in treatment?

Authors:  Ana Luisa G Calich; Diogo S Domiciano; Ricardo Fuller
Journal:  Clin Rheumatol       Date:  2010-01-27       Impact factor: 2.980

7.  Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia.

Authors:  Claudia Jakubzick; Esther S Choi; Kristin J Carpenter; Steven L Kunkel; Holly Evanoff; Fernando J Martinez; Kevin R Flaherty; Galen B Toews; Thomas V Colby; William D Travis; Bharat H Joshi; Raj K Puri; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

8.  The Role of Interleukin-4 and Interleukin-10 in Osteoarthritic Joint Disease: A Systematic Narrative Review.

Authors:  E M van Helvoort; E van der Heijden; J A G van Roon; N Eijkelkamp; S C Mastbergen
Journal:  Cartilage       Date:  2022 Apr-Jun       Impact factor: 3.117

9.  Cationic amino acid transporter-2 regulates immunity by modulating arginase activity.

Authors:  Robert W Thompson; John T Pesce; Thirumalai Ramalingam; Mark S Wilson; Sandy White; Allen W Cheever; Stacy M Ricklefs; Stephen F Porcella; Lili Li; Lesley G Ellies; Thomas A Wynn
Journal:  PLoS Pathog       Date:  2008-03-14       Impact factor: 6.823

10.  Cytokines in inflammatory bowel disease.

Authors:  P L Beck; J L Wallace
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.